Alnylam Pharmaceuticals Inc at UBS Global Healthcare Conference (Virtual) Transcript
Hello. Welcome to day 3 of the UBS Global Healthcare Conference. My name is Navin Jacob, senior analyst covering large-cap pharmaceuticals and mid-cap biotech. Our next presentation and fireside chat is with Alnylam. I'm happy to have with me Yvonne Greenstreet, Chief Operating Officer. Yvonne, thank you for joining us.
Thank you, Navin. I understand that I've got the prime slot, the last slot, so looking forward to be with everybody today on this call.
I thought it may be helpful, just to say a few words about Alnylam before we get into the questions. I mean, clearly, we're really excited about Alnylam's progress, and we now are a global multiproduct commercial company with 2 products on the market, ONPATTRO and GIVLAARI. I know we'll be talking about those here in a few minutes. Yes, another 2 products in registration with lumasiran as well as
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
